Stem Cells Spin S.A. (WSE:SCS)
Poland · Delayed Price · Currency is PLN 0.4680
-0.0020 (-0.43%)
At close: Aug 25, 2026
Stem Cells Spin Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.06 | 0.07 | 0.05 | 0.42 | 0.25 | 0.53 | |
Revenue Growth | -29.50% | 21.11% | -87.06% | 68.84% | -52.78% | 96.00% |
Cost of Revenue | 0.02 | 0.02 | 0.01 | 0.04 | 0.02 | 0.02 |
Gross Profit | 0.04 | 0.05 | 0.05 | 0.37 | 0.23 | 0.5 |
Selling, General & Admin | 0.15 | 0.11 | 0.11 | 0.12 | 0.11 | 0.29 |
Other Operating Expenses | -1.05 | -1.06 | -1.05 | -0.68 | -0.62 | -0.57 |
Operating Expenses | 0.63 | 0.57 | 0.56 | 0.53 | 0.44 | 0.58 |
Operating Income | -0.59 | -0.52 | -0.52 | -0.15 | -0.21 | -0.08 |
Interest Expense | -0.01 | -0.01 | -0 | -0 | -0 | -0.04 |
Other Non Operating Income (Expenses) | -0 | -0 | - | -0 | -0 | -0.01 |
EBT Excluding Unusual Items | -0.59 | -0.53 | -0.52 | -0.15 | -0.21 | -0.12 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.24 | -0 |
Pretax Income | -0.59 | -0.53 | -0.52 | -0.15 | 0.03 | -0.13 |
Net Income | -0.59 | -0.53 | -0.52 | -0.15 | 0.03 | -0.13 |
Net Income to Common | -0.59 | -0.53 | -0.52 | -0.15 | 0.03 | -0.13 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 41 | 41 |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 41 | 41 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.00 | 0.00 | -0.00 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.00 | 0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.12 | -0.09 | 0.04 | 0.09 | -0.6 | 0.66 |
Free Cash Flow Per Share | -0.00 | -0.00 | 0.00 | 0.00 | -0.01 | 0.02 |
Gross Margin | 68.67% | 75.05% | 86.17% | 89.36% | 91.75% | 95.49% |
Operating Margin | -1000.60% | -790.09% | -951.51% | -35.88% | -84.14% | -14.61% |
Profit Margin | -1011.28% | -799.60% | -958.49% | -36.81% | 10.71% | -24.23% |
Free Cash Flow Margin | -210.54% | -130.71% | 80.00% | 22.35% | -240.95% | 125.26% |
EBITDA | 0.94 | 1.01 | 0.98 | 0.93 | 0.75 | 0.77 |
EBITDA Margin | 1609.56% | 1533.58% | 1807.98% | 222.94% | 300.13% | 147.33% |
D&A For EBITDA | 1.53 | 1.53 | 1.5 | 1.09 | 0.95 | 0.85 |
EBIT | -0.59 | -0.52 | -0.52 | -0.15 | -0.21 | -0.08 |
EBIT Margin | - | - | - | -35.88% | -84.14% | -14.61% |
Revenue as Reported | 0.06 | 0.07 | 0.05 | 0.39 | 0.25 | 0.53 |